Dr. James Markert, MD
Claim this profileUniversity of Alabama at Birmingham
Studies Glioblastoma
Studies Fibrillary Astrocytoma
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials James Markert, MD is currently running
More about James Markert, MD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical TrialTreatments James Markert, MD has experience with
- C134
- M032
- Pembrolizumab
- M032 (NSC 733972)
Breakdown of trials James Markert, MD has run
Glioblastoma
Fibrillary Astrocytoma
Gliomas
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Markert, MD specialize in?
James Markert, MD focuses on Glioblastoma and Fibrillary Astrocytoma. In particular, much of their work with Glioblastoma has involved treating patients, or patients who are undergoing treatment.
Is James Markert, MD currently recruiting for clinical trials?
Yes, James Markert, MD is currently recruiting for 1 clinical trial in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that James Markert, MD has studied deeply?
Yes, James Markert, MD has studied treatments such as C134, M032, Pembrolizumab.
What is the best way to schedule an appointment with James Markert, MD?
Apply for one of the trials that James Markert, MD is conducting.
What is the office address of James Markert, MD?
The office of James Markert, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.